Experienced in Scaphoid Non-Union

Tim T. Wang

Hornsby, NSW, AU 
Experienced in Scaphoid Non-Union
Hornsby, NSW, AU 
OverviewLocationsClinical Research

Overview

Tim Wang practices in Hornsby, Australia. Mr. Wang is rated as an Experienced expert by MediFind in the treatment of Scaphoid Non-Union. His top areas of expertise are Osteomyelitis, Scaphoid Non-Union, Phantom Limb Pain, and Melanoma.

His clinical research consists of co-authoring 22 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Scaphoid Non-Union.

Gender
Male

Locations

Hornsby, NSW, Australia
Other Locations
Sydney, NSW, Australia
Westmead, NSW, Australia
Wahroonga, NSW, Australia
Royal North Shore Hospital, Reserve road
St Leonards, NSW 2065, Australia
Australia
Royal North Shore Hospital
North Shore, NSW, Australia
Camperdown, NSW, Australia
Wentworthville, NSW, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

LARK: Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)
LARK: Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)
Enrollment Status: Active_not_recruiting
Publish Date: April 04, 2025
Intervention Type: Device
Study Phase: Not Applicable
An Open-label, Single-arm, Phase I/II, Multicentre Study to Evaluate the Safety and Efficacy of the Combination of Dabrafenib, Trametinib and Palliative Radiotherapy in Patients with Unresectable (stage IIIc) and Metastatic (stage IV) BRAF V600E/K Mutation-positive Cutaneous Melanoma
An Open-label, Single-arm, Phase I/II, Multicentre Study to Evaluate the Safety and Efficacy of the Combination of Dabrafenib, Trametinib and Palliative Radiotherapy in Patients with Unresectable (stage IIIc) and Metastatic (stage IV) BRAF V600E/K Mutation-positive Cutaneous Melanoma
Enrollment Status: Completed
Publish Date: November 27, 2024
Intervention Type: Radiation, Drug
Study Drug: Dabrafenib and Trametinib (Combination)
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

22 Total Publications

Posterior ulnar recurrent artery perforator flap for elbow reconstruction: a forearm-based propeller flap.
Posterior ulnar recurrent artery perforator flap for elbow reconstruction: a forearm-based propeller flap.
Journal: Case reports in plastic surgery & hand surgery
Published: October 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wang's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile